YuLife announces US launch

Broadens reach into global markets

Hemma Visavadia
clock • 1 min read

Life insurtech YuLife has officially launched in the United States (US) after completing several funding rounds, which brought its total investment to $206m (£181m).

Investors in the insurtech include asset management giant T. Rowe Price Associates, Dai-ichi Life, Creandum, LocalGlobe, Target Global, Latitude, Anthemis, OurCrowd, Notion, MMC and Eurazeo. The expansion into the US will allow YuLife to broaden its reach into global markets and upscale its product range. Its current proposition is built upon rewards and benefits to employees for wellness activities and healthy habit changes using a gamified app that incorporates artificial intelligence and behavioural analytics. Sammy Rubin, chief executive and founder of YuLife, commented: "Insur...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on Individual Protection

The COVER Review: Protection sales, fit notes and long-term care

The COVER Review: Protection sales, fit notes and long-term care

Week commencing 18 May 2026

COVER
clock 22 May 2026 • 1 min read
Decline in new sales for most protection lines: Swiss Re Term & Health Watch

Decline in new sales for most protection lines: Swiss Re Term & Health Watch

L&G overtakes Aviva in term assurance sales

Jaskeet Briah
clock 21 May 2026 • 3 min read
Mental Health Awareness Week is not just for clients

Mental Health Awareness Week is not just for clients

Mental health resources and opinion

Cameron Roberts
clock 15 May 2026 • 4 min read